Viveve Medical, Inc. (VIVE)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Dec 27, 2024, 3:59 PM EST
Viveve Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | 2016 - 2012 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | 2016 - 2012 |
| Revenue | 6.83 | 6.43 | 5.48 | 6.57 | 18.52 | 15.29 | Upgrade
|
| Revenue Growth (YoY) | 2.38% | 17.28% | -16.57% | -64.54% | 21.12% | 114.09% | Upgrade
|
| Cost of Revenue | 5.71 | 5.81 | 5.18 | 5.55 | 11.2 | 7.84 | Upgrade
|
| Gross Profit | 1.12 | 0.62 | 0.3 | 1.02 | 7.32 | 7.44 | Upgrade
|
| Selling, General & Admin | 13.82 | 12.79 | 13.97 | 22.66 | 39.03 | 29.27 | Upgrade
|
| Research & Development | 8.44 | 9.39 | 4.83 | 8.29 | 13.26 | 11.9 | Upgrade
|
| Operating Expenses | 22.26 | 22.17 | 18.79 | 30.95 | 52.29 | 41.17 | Upgrade
|
| Operating Income | -21.14 | -21.55 | -18.5 | -29.94 | -44.97 | -33.73 | Upgrade
|
| Interest Expense | -1.11 | -1 | -0.91 | -4.35 | -4.37 | -3.17 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.09 | -0.2 | -0.29 | -0.16 | 0.01 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -22.28 | -22.76 | -19.69 | -34.45 | -49.32 | -36.96 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.74 | - | - | Upgrade
|
| Other Unusual Items | - | 0.99 | -1.84 | -6.71 | - | - | Upgrade
|
| Pretax Income | -22.73 | -21.77 | -21.53 | -41.9 | -49.32 | -36.96 | Upgrade
|
| Earnings From Continuing Operations | -22.73 | -21.77 | -21.53 | -41.9 | -49.32 | -36.96 | Upgrade
|
| Minority Interest in Earnings | -0.26 | -0.26 | -0.38 | -0.63 | -0.66 | - | Upgrade
|
| Net Income | -22.99 | -22.03 | -21.92 | -42.53 | -49.98 | -36.96 | Upgrade
|
| Preferred Dividends & Other Adjustments | 5.15 | 4.69 | 4.15 | 0.38 | - | - | Upgrade
|
| Net Income to Common | -28.14 | -26.72 | -26.06 | -42.91 | -49.98 | -36.96 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 10 | 2 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 10 | 2 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 33.25% | 541.22% | 1161.00% | 301.76% | 77.51% | - | Upgrade
|
| EPS (Basic) | -2.65 | -2.65 | -16.56 | -343.84 | -1609.23 | -2112.30 | Upgrade
|
| EPS (Diluted) | -2.65 | -2.65 | -16.56 | -343.84 | -1609.23 | -2112.30 | Upgrade
|
| Free Cash Flow | -16.83 | -13.33 | -16.02 | -32.32 | -45.23 | -35.76 | Upgrade
|
| Free Cash Flow Per Share | -1.58 | -1.32 | -10.18 | -259.03 | -1456.33 | -2043.66 | Upgrade
|
| Gross Margin | 16.39% | 9.65% | 5.40% | 15.47% | 39.53% | 48.69% | Upgrade
|
| Operating Margin | -309.73% | -335.40% | -337.56% | -455.87% | -242.83% | -220.63% | Upgrade
|
| Profit Margin | -412.17% | -415.78% | -475.71% | -653.36% | -269.92% | -241.75% | Upgrade
|
| Free Cash Flow Margin | -246.51% | -207.50% | -292.30% | -492.20% | -244.27% | -233.90% | Upgrade
|
| EBITDA | -20.34 | -20.43 | -17.2 | -28.76 | -44.18 | -33.28 | Upgrade
|
| EBITDA Margin | -297.90% | - | - | - | -238.59% | -217.69% | Upgrade
|
| D&A For EBITDA | 0.81 | 1.12 | 1.3 | 1.18 | 0.79 | 0.45 | Upgrade
|
| EBIT | -21.14 | -21.55 | -18.5 | -29.94 | -44.97 | -33.73 | Upgrade
|
| EBIT Margin | - | - | - | - | -242.83% | -220.63% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.